Adoptive Cellular Immunotherapy Improves Survival in Resected NSCLC – Cancer Therapy Advisor
Cancer Therapy Advisor |
Adoptive Cellular Immunotherapy Improves Survival in Resected NSCLC
Cancer Therapy Advisor Adjuvant adoptive cellular immunotherapy plus chemotherapy improved overall survival (OS) among patients with resected non-small-cell lung cancer (NSCLC) compared with chemotherapy alone, according to data presented at the European Society of … |
